Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 512

Similar articles for PubMed (Select 16051115)

1.

Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy.

Almquist AK, Montgomery JV, Haas TS, Maron BJ.

Heart Rhythm. 2005 Aug;2(8):814-9.

PMID:
16051115
2.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

3.

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L.

Pacing Clin Electrophysiol. 2003 Sep;26(9):1887-96.

PMID:
12930505
4.

Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties.

Przybylski A, Małecka L, Pytkowski M, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Ruzyłło W, Szwed H.

Kardiol Pol. 2005 Oct;63(4):391-7; discussion 398. English, Polish.

PMID:
16273479
5.

Management of hypertrophic cardiomyopathy in children.

Seggewiss H, Rigopoulos A.

Paediatr Drugs. 2003;5(10):663-72. Review.

PMID:
14510624
6.

Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1118-26. doi: 10.1111/j.1540-8167.2008.01147.x. Epub 2008 Mar 31. Review.

PMID:
18384577
7.

Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.

Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.

Rev Port Cardiol. 2005 Mar;24(3):407-15. English, Portuguese.

PMID:
15929624
8.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314
9.

Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.

J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

10.

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.

Cuoco FA, Spencer WH 3rd, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR.

J Am Coll Cardiol. 2008 Nov 18;52(21):1718-23. doi: 10.1016/j.jacc.2008.07.061.

11.

[Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation].

Jastrzebski M, Czarnecka D, Bacior B, Petkow-Dimitrow P, Wilczek R, Kawecka-Jaszcz K.

Kardiol Pol. 2005 Aug;63(2):191-5; discussion 196. Polish.

PMID:
16136416
12.

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA 3rd, Spirito P.

N Engl J Med. 2000 Feb 10;342(6):365-73.

13.

[Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].

Maron BJ, Spirito P.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Apr;37(4):297-302. Chinese.

PMID:
19791462
14.

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients.

Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A.

Heart Rhythm. 2008 Nov;5(11):1517-22. doi: 10.1016/j.hrthm.2008.08.021. Epub 2008 Aug 28.

PMID:
18984525
15.

Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.

Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.

J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):883-9. doi: 10.1111/j.1540-8167.2009.01716.x. Epub 2010 Feb 1.

PMID:
20132378
17.

[The implantable cardioverter-defibrillator: the Portuguese experience].

Adragão P, Neves J, Sousa J, Fançoni J, da Silva N, Antunes E, Elvas L, Bernardo J.

Rev Port Cardiol. 1997 Apr;16(4):367-74, 351-2. Portuguese. Erratum in: Rev Port Cardiol 1997 Jul-Aug;16(7-8):645.

PMID:
9254126
18.

Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator.

Primo J, Geelen P, Brugada J, Filho AL, Mont L, Wellens F, Valentino M, Brugada P.

J Am Coll Cardiol. 1998 Apr;31(5):1081-5.

19.

Implantable cardioverter defibrillator therapy for life-threatening arrhythmias in young patients.

Stefanelli CB, Bradley DJ, Leroy S, Dick M 2nd, Serwer GA, Fischbach PS.

J Interv Card Electrophysiol. 2002 Jul;6(3):235-44.

PMID:
12154326
20.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P.

JAMA. 2007 Jul 25;298(4):405-12. Erratum in: JAMA. 2007 Oct 3;298(13):1516.

PMID:
17652294
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk